Shane Lloyd
Shane Lloyd
Verified email at hci.utah.edu
Title
Cited by
Cited by
Year
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy
S Lloyd, BY James, LD Wilson, RH Decker
American journal of clinical oncology 34 (1), 76-81, 2011
1342011
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance.
HS Park, S Lloyd, RH Decker, LD Wilson, JB Yu
Current problems in cancer 36 (4), 183-190, 2012
812012
Limitations and biases of the Surveillance, Epidemiology, and End Results database
HS Park, S Lloyd, RH Decker, LD Wilson, BY James
Current problems in cancer 36 (4), 216-224, 2012
642012
A prognostic index for predicting lymph node metastasis in minor salivary gland cancer
S Lloyd, BY James, DA Ross, LD Wilson, RH Decker
International Journal of Radiation Oncology* Biology* Physics 76 (1), 169-175, 2010
522010
Current strategies in chemoradiation for esophageal cancer
S Lloyd, BW Chang
Journal of gastrointestinal oncology 5 (3), 156, 2014
482014
A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer
MS Moran, S Ma, R Jagsi, TIJ Yang, SA Higgins, JB Weidhaas, LD Wilson, ...
International Journal of Radiation Oncology* Biology* Physics 85 (1), 40-46, 2013
382013
ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II
NG Zaorsky, TN Showalter, GA Ezzell, PL Nguyen, DG Assimos, ...
Advances in radiation oncology 2 (3), 437-454, 2017
332017
Increased risk of death due to heart disease after radiotherapy for esophageal cancer
J Frandsen, D Boothe, DK Gaffney, BD Wilson, S Lloyd
Journal of gastrointestinal oncology 6 (5), 516, 2015
332015
Treatment‐related determinants of survival in early‐stage (T1–2N0M0) oral cavity cancer: A population‐based study
JC Sowder, RB Cannon, LO Buchmann, JP Hunt, Y Hitchcock, S Lloyd, ...
Head & neck 39 (5), 876-880, 2017
292017
Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer
A Torgeson, S Lloyd, D Boothe, R Tao, J Whisenant, I Garrido‐Laguna, ...
Cancer 123 (19), 3816-3824, 2017
282017
Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides
S Lloyd, Z Chen, FM Foss, M Girardi, LD Wilson
Journal of the American Academy of Dermatology 69 (4), 537-543, 2013
232013
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer
BJ Davis, AV Taira, PL Nguyen, DG Assimos, AV D'Amico, AR Gottschalk, ...
Brachytherapy 16 (2), 266-276, 2017
202017
Increasing use of nonsurgical therapy in advanced‐stage oral cavity cancer: A population‐based study
RB Cannon, JC Sowder, LO Buchmann, JP Hunt, YJ Hitchcock, S Lloyd, ...
Head & neck 39 (1), 82-91, 2017
202017
Correlates of refusal of surgery in the treatment of non-metastatic pancreatic adenocarcinoma
A Coffman, A Torgeson, S Lloyd
Annals of surgical oncology 26 (1), 98-108, 2019
192019
Toxicity and outcomes in patients with and without esophageal stents in locally advanced esophageal cancer
SR Francis, A Orton, C Thorpe, G Stoddard, S Lloyd, CJ Anker
International Journal of Radiation Oncology* Biology* Physics 99 (4), 884-894, 2017
192017
Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins
A Torgeson, I Garrido-Laguna, R Tao, GM Cannon, CL Scaife, S Lloyd
ESMO open 3 (1), e000282, 2018
182018
Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle
S Gajiwala, A Torgeson, I Garrido-Laguna, C Kinsey, S Lloyd
Journal of gastrointestinal oncology 9 (6), 1014, 2018
172018
A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer
S Lloyd, BW Chang
Journal of gastrointestinal oncology 4 (2), 123, 2013
172013
Chemoradiation therapy for unresected extrahepatic cholangiocarcinoma: A propensity score-matched analysis
A Torgeson, S Lloyd, D Boothe, G Cannon, I Garrido-Laguna, ...
Annals of surgical oncology 24 (13), 4001-4008, 2017
122017
Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.
S Lloyd, HS Park, RH Decker, LD Wilson, JB Yu
Current problems in cancer 36 (4), 191-199, 2012
112012
The system can't perform the operation now. Try again later.
Articles 1–20